WELCOME TO MASS INNOVATION LABS

Mass Innovation Labs is a new approach to providing research scientists with an on-demand, pharma-grade research environment to accelerate scientific discovery and therapeutic commercialization.

Our goal at Mass Innovation Labs is to minimize any administrative and logistical hurdles your team faces on its way to reaching important research milestones. We provide a turnkey laboratory environment that allows you to focus on scientific discovery from day one.

Amrit Chaudhuri, CEO

Amrit Chaudhuri is the CEO and co-founder of Mass Innovation Labs. Amrit is a recognized leader and ardent entrepreneur in the area of drug development. He is the founder of Advanced Peptides, a specialty contract research organization focused on peptide chemistry.

Amrit holds numerous patents, has created five successful companies, and has been involved in many FDA clinical trials. In 2017, Amrit was named one of INC Magazine's Top 20 Healthcare Innovators and Entrepreneurs.

Seth Taylor, CFO

Seth Taylor is the CFO and co-founder of Mass Innovation Labs. Seth has more than 17 years of industry experience that combines business development, corporate advisory services and the founding of life science companies.

As Managing General Partner of Vectur LLC and as Principal at TSG Partners, Seth developed growth strategies and worked on a wide range of strategic mandates for leading life science companies. He was cofounder of Molecularware, Inc., a life science information company, and prior to that, he served as an executive in business development at Packard Bioscience.

Seth holds an MBA from the Sloane School of Business at MIT and a Ph.D. from Johns Hopkins University in Molecular Biology.

Hans Ludi, Director of Operations

Hans Ludi is the Director of Operations at Mass Innovation Labs. Hans has decades of experience in the life sciences and technology industries and has held a variety of technical and management positions in the areas of research and technology management. Throughout his career, Hans has focused on commercializing advanced technology projects in partnership with corporations and VC's.

Hans holds a Masters Diploma in Biochemistry and Microbiology from the Federal Institute of Technology in Zürich, Switzerland and a Ph.D. in Biochemistry from the University of Bern, Switzerland.